Diagnosis of Polycystic Ovary Syndrome

    February 2007 in “ Clinical Obstetrics and Gynecology
    Bradley Trivax, Ricardo Azziz
    Image of study
    TLDR The definition of Polycystic Ovary Syndrome may change with new research, and careful screening is key for managing the condition.
    In 2007, Bradley Trivax and Ricardo Azziz reviewed the diagnostic criteria for Polycystic Ovary Syndrome (PCOS), a common endocrine disorder affecting at least 1 in 15 women of reproductive age. They discussed three sets of criteria: NIH 1990, Rotterdam 2003, and Androgen Excess Society 2006, which vary in their requirements but all include hyperandrogenism and ovulatory dysfunction. The prevalence of PCOS was reported to be around 6.5% using the NIH 1990 criteria. The paper also noted that while insulin resistance and obesity are common in PCOS, they are not part of the diagnostic criteria. The document highlighted that 72% of 716 PCOS patients in the Southeastern United States exhibited hirsutism, 70% had hyperandrogenemia, 60% to 85% had menstrual irregularities, and 70% to 100% had polycystic ovarian morphology on ultrasonography. It emphasized the importance of excluding other disorders and evaluating for associated conditions like insulin resistance and type 2 diabetes. The paper concluded that the definition of PCOS is likely to evolve with new research and that screening and evaluation for PCOS are crucial for effective management.
    Discuss this study in the Community →

    Research cited in this study

    5 / 5 results

    Related Community Posts Join

    6 / 22 results

      community PCOS Hair Loss: What’s Helped Me (and What Didn’t)

      in Treatment  11 upvotes 6 months ago
      OP shares their experience with PCOS-related hair loss, highlighting that addressing vitamin D and ferritin deficiencies, managing hormones with spironolactone, and using gentle hair care products helped improve their condition. They advise against relying on "miracle" hair oils and emphasize the importance of medical evaluation and a combined approach to treatment.

      community Female, 30, PCOS diagnosis, MPB Norwood 2. Endo refuses to give anything other than Spironolactone. Feel like I’m at my wit’s end here.

      in Female  54 upvotes 2 years ago
      A 30-year-old female with PCOS and male pattern baldness is frustrated with her endocrinologist's recommendation of only Spironolactone and minoxidil, feeling that dutasteride, finasteride, and progesterone would be more effective. Other users suggest various online sources for treatments, warn against self-medicating due to potential risks, and recommend seeking a specialized endocrinologist or considering additional treatments like Inositol, Berberine, and dermaneedling.

      community Sugar and Hair loss connections

      in Research/Science  41 upvotes 10 months ago
      High sugar diets may worsen hair loss by increasing 5α-reductase activity and androgen levels, especially in women with PCOS. A low sugar diet might reduce scalp DHT levels, similar to finasteride, but genetics also significantly influence hair loss.

      community How does hair loss and recovery work?

      in Chat  12 upvotes 1 year ago
      Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.

    Related Research

    1 / 1 results